Cite
HARVARD Citation
Perez-Fidalgo, J. et al. (2019). GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer. Future science OA. p. . [Online].